CHAM
PGNX

Clear Harbor Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Clear Harbor Asset Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-60,330
Closed -$485K – 288
2018
Q2 		$485K Hold
60,330
– – 0.09% 144
2018
Q1 		$450K Sell
60,330
-1,680
-3% -$11.2K 0.09% 146
2017
Q4 		$369K Sell
62,010
-660
-1% -$4.01K 0.07% 163
2017
Q3 		$461K Sell
62,670
-9,260
-13% -$58.8K 0.09% 153
2017
Q2 		$493K Buy
71,930
+19,330
+37% +$143K 0.09% 145
2017
Q1 		$497K Hold
52,600
– – 0.1% 142
2016
Q4 		$454K Sell
52,600
-810
-2% -$5.99K 0.1% 143
2016
Q3 		$338K Sell
53,410
-2,850
-5% -$17.2K 0.07% 170
2016
Q2 		$237K Sell
56,260
-540
-1% -$2.61K 0.05% 210
2016
Q1 		$248K Sell
56,800
-50
-0.1% -$223 0.05% 196
2015
Q4 		$348K Sell
56,850
-810
-1% -$5.31K 0.08% 171
2015
Q3 		$330K Sell
57,660
-120
-0.2% -$921 0.08% 190
2015
Q2 		$431K Buy
57,780
+300
+0.5% +$1.81K 0.08% 177
2015
Q1 		$344K Sell
57,480
-2,070
-3% -$13K 0.07% 201
2014
Q4 		$450K Sell
59,550
-10,150
-15% -$60.7K 0.09% 176
2014
Q3 		$362K Buy
69,700
+47,600
+215% +$237K 0.08% 152
2014
Q2 		$95K Buy
22,100
+3,100
+16% +$11.8K 0.02% 212
2014
Q1 		$78K Sell
19,000
-1,000
-5% -$5.11K 0.02% 202
2013
Q4 		$107K Buy
+20,000
New +$88K 0.03% 175

Other funds holding PGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Clear Harbor Asset Management's PGNX Position: Q3 2018 in Review

Clear Harbor Asset Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q3 2018, closing a stake of 60,330 shares — an estimated $485K sold.

Clear Harbor Asset Management first reported a position in PGNX in Q4 2013 and held it in 19 quarters. The position peaked at $497K in Q1 2017. 148 funds tracked by Wall St. Rank hold PGNX as of Q3 2018.

  • Clear Harbor Asset Management reported no remaining Progenics Pharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • Clear Harbor Asset Management sold 60,330 Progenics Pharmaceuticals Inc shares in Q3 2018, an estimated $485K.
  • Clear Harbor Asset Management first reported a position in Progenics Pharmaceuticals Inc in Q4 2013 and held it in 19 quarters.
  • Clear Harbor Asset Management's Progenics Pharmaceuticals Inc position peaked at $497K in Q1 2017.
  • 148 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2018.

Based on Clear Harbor Asset Management's 13F filing for Q3 2018, filed 26 Oct 2018.